Homatropine and psychosis in Weill-Marchesani syndrome.
Madugula
Anjaiah
A
Chandrasekaran
Ramamurthi
R
Rakesh
Goyal
G
D000015:Abnormalities, Multiple; D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D005124:Eye Abnormalities / Q000601:surgery; D006212:Hallucinations / Q000209:etiology*; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use*; D008297:Male; D000077152:Olanzapine; D013577:Syndrome; D014130:Trabeculectomy; D014326:Tropanes / Q000009:adverse effects*
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D014326:Tropanes; D001569:Benzodiazepines; C100236:homatropine; D000077152:Olanzapine; D008140:Lorazepam